Quarterly report pursuant to Section 13 or 15(d)

Note 9 - Accounts Payable, Accrued Liabilities and Other

v3.7.0.1
Note 9 - Accounts Payable, Accrued Liabilities and Other
6 Months Ended
Jun. 30, 2017
Notes to Financial Statements  
Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]
9.
Accounts Payable, Accrued Liabilities and Other
 
Accounts payable at
June 30, 2017
and
December 31, 2016
includes an aggregate of
$1,000
and
$116,000,
respectively, due to related parties related to director fees and MT scientific advisory board fees. At
June 30, 2017,
approximately
$210,000
of accounts payable is being disputed by the Company related to unauthorized expenditures by a former executive and related legal fees incurred during the year ended
December 31, 2016.
 
Accrued liabilities and other at
June 30, 2017
includes
$64,000
due to related parties for director fees. Accrued liabilities and other at
December 31, 2016
includes an aggregate of
$106,000
due to related parties for executive bonuses, director fees, deferred salary owed to Dr. Goldberg, and MT scientific advisory board fees.